Clinical Trial Update: Autologous Cord Blood Cells for Prevention of BPD in Preterm [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating autologous cord blood cells to prevent bronchopulmonary dysplasia in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Autologous cord blood cells

Snippet

Sponsor: yangjie | Conditions: Safety Issues, BPD - Bronchopulmonary Dysplasia | Phase 2 | Status: COMPLETED